Navigating the Complexity of Gene Therapy
Many cell and gene therapies can prove difficult for reimbursement due to their high cost and complicated risk-to-benefit ratio. When that therapy is a lifesaving medication, it makes the issue of patient access paramount.
In the latest case study from UBC, we discuss how our patient access team worked incredibly closely with the sponsor to create a program tailored to this unique pediatric population and therapy. This spinal muscular atrophy (SMA) gene therapy provided unique challenges for our case managers. Find out how our team overcame:
- A complex manufacturing and distribution channel
- Uncertain payer coverage for a high-cost product
- FDA requirements for a pre-treatment companion diagnostic
- Coordinating and communicating with almost a dozen closely involved stakeholders
Download the case study today using the form to the right.
Want to know more about us?
Subscribe Now
Want to know more about us?
Subscribe Now
Providers
Thank You for Connecting with UBC
Lorem ipsum dolor sit amet consectetur. Mi proin enim ipsum nascetur. Venenatis odio scelerisque non netus ac et pellentesque.
What You Can Expect Next
Lorem ipsum dolor sit amet consectetur. Cras aliquam erat eget magna sollicitudin.
- Leverage automation to move fast
- Always give customers a human to chat to
- Automate customer support and close leads faster
Get Ready to Change Your Business
Lorem ipsum dolor sit amet consectetur. Mi proin enim ipsum nascetur. Venenatis odio scelerisque non netus ac et pellentesque.
Service Request
Bekki Bracken Brown
President & Chief Executive Officer
Bekki Bracken Brown serves as the President and CEO of UBC, guiding the company’s mission and values, including the improvement of access for patients to receive better outcomes. She oversees all aspects of UBC, such as operations, business growth strategy, sales and marketing, and acquisition support.
With over 20 years of industry experience, Ms. Brown brings knowledge from a successful career in senior management from her tenure at Quintiles, INC Research, and, most recently, with Syneos Health. She’s been a member of the North Carolina BIO Board of Directors since 2019. She is also a member of the Healthcare Businesswomen’s Association — Southeast Chapter and CHIEF, an organization that supports women executive leaders. Ms. Brown earned her bachelor’s degree at Duke University.